The United States infant formula market size is estimated to be valued at USD 7.53 Billion in 2025. It can reach a valuation of USD 10.32 Billion by 2032, by exhibiting a CAGR of 4.6% throughout the forecast period (2025-2032).  

The inclination of parents to spend on infant formulas for their baby’s development and the increasing number of women in the workforce are primary drivers of the market. The huge demand for clean-label ingredients and transparency in infant formulas also presents a novel opportunity in the market.

However, stringent regulations imposed by the U.S. Food and Drug Administration (FDA) on infant formulas and their compliance to the Federal Food, Drug, and Cosmetic Act can hamper the market growth.

Key Market Insights

The United States infant formula market is likely to be shaped by the deep penetration of e-commerce and the expansion of manufacturers into probiotic-infused formulas.

• By formulation, the powder segment is expected to capture a 33.0% share of the market in 2025. The demand within the segment can be attributed to its long shelf life and ease of storage. This will be heightened by its popularity across retail and online channels.
• By distribution channel, the hypermarkets segment is anticipated to attain a significant market share of 24.0% in 2025. The significance of this distribution channel can be attributed to their nationwide reach, competitive pricing, and product offerings. The combination of convenience and affordability at hypermarkets can drive up its market share over the forecast period.

The full report is now available for purchase: https://www.coherentmi.com/industry-reports/united-states-infant-formula-market

United States Infant Formula Market Report Coverage

Report Coverage	Details
Market Revenue in 2025	USD 7.53 Billion
Estimated Value by 2032	USD 10.32 Billion
Growth Rate	4.6%
Historical Data	2020–2024
Forecast Period	2025–2032
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	By Formulation and Distribution Channel
Growth Drivers	Rising Per Capita Income Working Women Population Growth
Opportunities	Premium/Organic Product Segment Developing Private Label Brands
Trends	Expansion of Clean Labels Innovation in Plant-based Organic Formulas
Restraints & Challenges	Stringent Regulations High Research and Development Costs

Market Dynamics

The proposal to increase the resilience of the infant formula supply chain can positively impact the United States infant formula market. The infant formula shortage, which began in the fall of 2022 and continued into the summer of 2023, led to anxiety among parents and infant formula producers. The spate of contamination concerns in formulas led to the closure of various factories and a slew of cases against prominent companies.

The proposal of a long-term strategy proposed by the U.S. FDA in May 2023 highlighted measures for incumbents and welcomed new formula manufacturers. The proactive measures also intended to strengthen the supply chain by collaborating with stakeholders at federal, state, local, territorial, and grassroots levels. Another step was to continually update regulations to ensure the product remained safe and easier to consume. This can lead to an increase in quality evaluations and assessments by manufacturers, providing a sense of relief to customers.

Market Opportunity: Expansion into Functional and Probiotic-Infused Formulas

The focus on functional nutrition through the integration of probiotics and functional ingredients can drive the United States infant formula market. This is spurred by the establishment of R&D centers for the development of generally regarded as safe (GRAS) ingredients. The demand driven by consumer awareness and pediatric recommendations can contribute to holistic wellness in children’s nutrition. With the U.S. FDA allowing various methods for clinical validation of functional ingredients, manufacturers have various opportunities for setting new standards in infant nutrition. For instance, Happy Family Organics launched a new line of infant formulas on September 26, 2024. The line, Happy Baby Infant Formulas, are USDA-certified and modeled after breast milk.

Market Challenge: Recall of Infant Formulas

The recall of infant formulas made by prominent manufacturers due to stringent regulations poses a significant challenge to the market. The short supply of infant formulas can be a blow for working mothers and other parents looking to wean babies quickly. According to a report published by the University of Kansas on March 10, 2025, infant formulas contain high levels of added elements instead of nutritional ones. The unscrupulous practices by manufacturers have led to customers turning to organic baby formulas, which adhere to regulations prescribed by regulatory agencies.

Analyst’s View

• The focus on clean-label products and non-GMO infant formulas can drive the United States infant formula market growth.
• The powder segment can account for a significant market share in 2025, owing to powdered formulas being a widely accepted choice among parents.
• Key players are focusing on innovations to be abreast of stringent government regulations and the launch of functional ingredient-focused formulas.

Recent Developments

Bobbie Baby Inc. launched a new product, Bobbie Organic Whole Milk Infant Formula, on March 10, 2025.

Competitor Insights

• Nestlé S.A.
• Abbott Laboratories
• Arla Foods amba
• Danone S.A.
• Else Nutrition Holdings Inc.
• Walmart Inc.
• Reckitt Benckiser Group PLC
• Target Corporation
• Bobbie Baby, Inc.
• Aussie Bubs, Inc.

Market Segmentation

• By Formulation
• Ready to Feed
• Powder
• Liquid Concentrate
• By Distribution Channel
• Online
• Hypermarkets
• Supermarkets
• Specialty Stores
• Others